Technical Report abstract


Nature Medicine 13, 754 - 759 (2007)
Published online: 7 May 2007 | doi:10.1038/nm1559

An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS

Rishi Rakhit1, Janice Robertson2, Christine Vande Velde3, Patrick Horne2, Deborah M Ruth2, Jennifer Griffin2, Don W Cleveland3, Neil R Cashman2,4 & Avijit Chakrabartty1


Misfolding of Cu/Zn-superoxide dismutase (SOD1) is emerging as a mechanism underlying motor neuron degeneration in individuals with amyotrophic lateral sclerosis (ALS) who carry a mutant SOD1 gene (SOD1 ALS). Here we describe a structure-guided approach to developing an antibody that specifically recognizes monomer-misfolded forms of SOD1. We raised this antibody to an epitope that is normally buried in the SOD1 native homodimer interface. The SOD1 exposed dimer interface (SEDI) antibody recognizes only those SOD1 conformations in which the native dimer is disrupted or misfolded and thereby exposes the hydrophobic dimer interface. Using the SEDI antibody, we established the presence of monomer-misfolded SOD1 in three ALS mouse models, with G37R, G85R and G93A SOD1 mutations, and in a human individual with an A4V SOD1 mutation. Despite ubiquitous expression, misfolded SOD1 was found primarily within degenerating motor neurons. Misfolded SOD1 appeared before the onset of symptoms and decreased at the end stage of the disease, concomitant with motor neuron loss.

Top
  1. Departments of Biochemistry and Medical Biophysics, University of Toronto and Ontario Cancer Institute, 101 College Street, Toronto, Ontario M5G 1L7, Canada.
  2. Centre for Research in Neurodegenerative Diseases, and Department of Laboratory Medicine and Pathobiology, University of Toronto, 6 Queen's Park Crescent West, Toronto, Ontario M5S 3H2, Canada.
  3. Ludwig Institute for Cancer Research and University of California at San Diego, 9500 Gilman Drive, La Jolla, California 92093, USA.
  4. Present address: Department of Medicine (Neurology) and Brain Research Centre, University of British Columbia Hospital, University of British Columbia, 2211 Wesbrook Mall, Vancouver, British Columbia V6T 2B5, Canada.

Correspondence to: Avijit Chakrabartty1 e-mail: chakrab@uhnres.utoronto.ca



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Putting the heat on ALS

Nature Medicine News and Views (01 Apr 2004)

Motor neuron disease The curious ways of ALS

Nature News and Views (17 Jul 2008)

See all 6 matches for News And Views

Extra navigation

Subscribe to Nature Medicine

Subscribe

Open Innovation Challenges

ADVERTISEMENT